中文版 | English
题名

NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming

作者
通讯作者Hutchins, Andrew P.; Esteban, Miguel A.
发表日期
2018-04
DOI
发表期刊
ISSN
1465-7392
EISSN
1476-4679
卷号20期号:4页码:400-+
摘要
Somatic cell reprogramming by exogenous factors requires cooperation with transcriptional co-activators and co-repressors to effectively remodel the epigenetic environment. How this interplay is regulated remains poorly understood. Here, we demonstrate that NCoR/SMRT co-repressors bind to pluripotency loci to create a barrier to reprogramming with the four Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC), and consequently, suppressing NCoR/SMRT significantly enhances reprogramming efficiency and kinetics. The core epigenetic subunit of the NCoR/SMRT complex, histone deacetylase 3 (HDAC3), contributes to the effects of NCoR/SMRT by inducing histone deacetylation at pluripotency loci. Among the Yamanaka factors, recruitment of NCoR/SMRT-HDAC3 to genomic loci is mostly facilitated by c-MYC. Hence, we describe how c-MYC is beneficial for the early phase of reprogramming but deleterious later. Overall, we uncover a role for NCoR/SMRT co-repressors in reprogramming and propose a dual function for c-MYC in this process.
相关链接[来源记录]
收录类别
语种
英语
重要成果
NI期刊
学校署名
通讯
资助项目
Science and Technology Planning Project of Guangdong Province, China[2017B030314056]
WOS研究方向
Cell Biology
WOS类目
Cell Biology
WOS记录号
WOS:000428781900010
出版者
ESI学科分类
MOLECULAR BIOLOGY & GENETICS
来源库
Web of Science
引用统计
被引频次[WOS]:57
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/27903
专题生命科学学院_生物系
作者单位
1.Guangzhou Med Univ, Joint Sch Life Sci, Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China
2.Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China
3.Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab RNA Chromatin & Human Dis, Guangzhou, Guangdong, Peoples R China
4.Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China
5.Univ Chinese Acad Sci, Beijing, Peoples R China
6.Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou, Guangdong, Peoples R China
7.Quaid I Azam Univ, Dept Biochem, Islamabad, Pakistan
8.Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Metab & Cell Fate, Guangzhou, Guangdong, Peoples R China
9.Anhui Univ, Inst Hlth Sci, Hefei, Anhui, Peoples R China
10.Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
11.Southern Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China
12.Guangzhou FitGene Biotechnol Co Ltd, Guangzhou, Guangdong, Peoples R China
13.Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Drug Discovery Pipeline, Guangzhou, Guangdong, Peoples R China
14.Univ Hong Kong, Hong Kong Guangdong Joint Lab Stem Cells & Regene, Hong Kong, Hong Kong, Peoples R China
15.Guangzhou Inst Biomed & Hlth, Hong Kong, Hong Kong, Peoples R China
16.Univ Hong Kong, Shenzhen Inst Res & Innovat, Hong Kong, Hong Kong, Peoples R China
17.Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
通讯作者单位生物系
推荐引用方式
GB/T 7714
Zhuang, Qiang,Li, Wenjuan,Benda, Christina,et al. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming[J]. NATURE CELL BIOLOGY,2018,20(4):400-+.
APA
Zhuang, Qiang.,Li, Wenjuan.,Benda, Christina.,Huang, Zhijian.,Ahmed, Tanveer.,...&Esteban, Miguel A..(2018).NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.NATURE CELL BIOLOGY,20(4),400-+.
MLA
Zhuang, Qiang,et al."NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming".NATURE CELL BIOLOGY 20.4(2018):400-+.
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Zhuang, Qiang]的文章
[Li, Wenjuan]的文章
[Benda, Christina]的文章
百度学术
百度学术中相似的文章
[Zhuang, Qiang]的文章
[Li, Wenjuan]的文章
[Benda, Christina]的文章
必应学术
必应学术中相似的文章
[Zhuang, Qiang]的文章
[Li, Wenjuan]的文章
[Benda, Christina]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。